CCL2 and cancer: When the inflammasomes are abnormally activated, a variety of inflammatory cytokines and chemokines, including TNF-α, IL-1β, IL-6, IL-18, CCL2/MCP-1, are excessively secreted, which affect the development of cancer (40, 41).